Business Wire

EZTD Inc. Business and Trading Update and Listing on OTC Bulletin Board

Del

EZTD Inc. (OTCQB:EZTD) (“EZTD” or “the Company”), a worldwide leader of online binary options trading, is pleased to announce that its common stock has been approved for quotation on the U.S. over-the-counter bulletin board (OTCBB) and to provide an update on its business and trading for the nine-month period ended September 30, 2015.

Business and Trading Update

EZTD has developed and currently operates an online trading platform allowing retail customers to trade a wide range of binary options internationally with more than 100 different assets. The Company’s proprietary trading platform is accessible from multiple operating systems (Windows, Safari, iOS and Android, and mobile apps). It is designed to be as intuitive and user-friendly as possible.

During the nine-month period ended September 30, 2015, the Company invested in new sponsorships and increased it investments in brands and new technology.

The Company generated revenues primarily from its binary options business. The Company’s total revenues for the nine months ended September 30, 2015 increased by 36% to approximately $19.5 million, from approximately $14.3 million for the nine months ended September 30, 2014. This growth is mainly due to the Company’s increased spending on customer acquisition, website development, R&D and marketing.

In addition, the Company reported positive adjusted EBITDA of $730,000 for the nine months ended September 30, 2015, while in the nine months ended September 30, 2014 the Company had negative adjusted EBITDA of $1.1 million.*

“We are delighted to have commenced trading in the public marketplace and are committed to providing our investors with information on the Company and the progress it makes,” said Shimon Citron, EZTD’s Chief Executive Officer. “We look forward to continuing to provide excellent service to all of our customers and we expect to finish 2015 with approximately $25 million in annual revenues,” Citron concluded.

* See ‘Reconciliation of EBITDA and Adjusted EBITDA to Net Income’ below.

About EZTD Inc.

Launched in June 2011, EZTD (formerly, EZTRADER Inc.) is one of the pioneers of secure and regulated online binary trading and maintains its position as a leading, reputable and reliable binary options platform. The Company offers 24/7 trading on more than 120 assets including commodities, stocks, currency pairs and indexes.

Currently available in more than 11 languages, the Company is growing rapidly and continues to seek exciting opportunities to further enhance its presence throughout Europe. The Company’s advanced mobile app is user-friendly and secure, and is available for both Android and iOS-compatible smartphones and tablets. EZTD is a sponsor to some of the leading sports teams in Europe. The Company is authorized by CYSEC throughout Europe.

Cautionary Note Regarding Forward-Looking Statements

This news release contains forward-looking statements. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “plan,” “project,” “potential,” “seek,” "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. For example, when the Company discusses its expected 2015 revenues it is using a forward-looking statement. Readers are cautioned that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company's results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company's filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

 

RECONCILIATION OF EBITDA AND ADJUSTED EBITDA TO NET INCOME

U.S. dollars in thousands.

   

Nine months ended

September 30,
2015

 

September 30,
2014

Unaudited
Net loss $ (3,711 ) $ (7,261 )
Add: Financial expenses, net 2,229 755
Add: Income taxes

-

-
Add: Depreciation and amortization 325 143
Add: Impairment of bank deposits   -     4,122  
EBITDA   (1,157 )   (2,241 )
Add: Other (income) expense 608 -
Add: Stock-based compensation   1,279     1,182  
Adjusted EBITDA $ 730   $ (1,059 )

The table above reconciles net income to EBITDA and Adjusted EBITDA. EBITDA is defined as net income before net interest expense, income taxes, depreciation and amortization and a one-time expense of a non-recurring loss due to the bankruptcy of Corporate Commercial Bank in Bulgaria, which is not relevant to forward-looking analyses and is not linked to the Company’s operational performance. Adjusted EBITDA is defined as EBITDA before other operating expenses related to the acquisition of a subsidiary in Japan and a regulatory fine, and expenses related to stock-based compensation. Although EBITDA and Adjusted EBITDA are not measures of performance calculated in accordance with GAAP, management believes that they are useful to the Company and to an investor in evaluating the Company because they are widely used measures to evaluate a company’s operating performance.

Contact information

Luther Pendragon
Alexis Gore
+44 207 618 9100
www.eztd.info

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Interactive Brokers Launches Bitcoin Futures Trading at the Start of Trading December 10th, 201711.12.2017 16:28Pressemelding

Interactive Brokers Group, Inc. (NASDAQ GS:IBKR), a global electronic brokerage firm, began offering clients the ability to trade bitcoin futures at the start of trading on the Cboe Futures Exchange (CFE) on Sunday night, December 10th, 2017. In addition to offering bitcoin futures from the CFE, under the ticker symbol GXBT, the company plans to offer bitcoin futures from the Chicago Mercantile Exchange (CME) at the scheduled start of trading December 18th using the symbol BRR. IBKR was there at the start of trading and its systems operated normally. “Interactive Brokers was on the buy side of the low print of 14,710,” said Thomas Peterffy, founder, Chairman and CEO of Interactive Brokers. “A Registered Investment Advisor on the Interactive Brokers platform purchased two March contracts in the first minute of trading.” As of 9:15am ET on Monday, the company said that

Boehringer Ingelheim Marks Great Progress in Immuno-oncology Research Partnerships in 201711.12.2017 13:00Pressemelding

2017 marks a year of significant advancement for Boehringer Ingelheim as it secured a range of external partnerships with the goal of transforming the lives of patients and winning the fight against cancer. External partnerships complement Boehringer Ingelheim’s two-pronged research strategy – investigating both cancer cell-directed therapies and immune cell-directed therapies. This multi-faceted approach offers the potential to bring innovative opportunities to the Boehringer Ingelheim oncology portfolio and novel therapies to patients. “Immuno-oncology is radically shifting the research and treatment landscape in oncology. We believe that the greatest success in difficult-to-treat cancers will be achieved with immuno-oncology and its combination with cancer cell directed therapy, which is why we are committing significant resources in both areas,” said Jonathon Sedgwick, Ph.D., Vice

Valence Advises SK Capital on Its Acquisition of ICL’s Fire Safety and Oil Additives Businesses11.12.2017 12:47Pressemelding

The Valence Group acted as lead financial advisor to SK Capital Partners on its announced acquisition of the Fire Safety and Oil Additives businesses of Israel Chemicals Ltd. (“ICL”) for approximately $1 billion. The transaction is expected to close during the first half of 2018. The Businesses, headquartered in St. Louis, Missouri, have global operations and are market leaders in each of their segments. The ICL Fire Safety business is a formulator and manufacturer of fire management chemicals. Its Phos-Chek fire retardants, Class A and B foams, and water enhancing gels are the world’s leading chemical solutions for managing wildland, military, industrial and municipal fires, and are used in partnership with fire management agencies across the globe. The ICL Oil Additives business provides high quality phosphorus pentasulfide used in the preparation of ZDDP-based lubricant additives, i

Smith & Nephew Announce European Launch of Handheld Imaging Technology Heralding a New Era of Evidence-Based Decision Making in Wound Care11.12.2017 10:18Pressemelding

Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the European launch of MolecuLight i:X TM, the easy to use, handheld imaging device that instantly measures wound surface area and visualises the presence and distribution of potentially harmful bacteria in wounds.2,3 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171211005434/en/ Currently wound assessments are made with the naked eye which can lack the accuracy required to most effectively guide clinical decision making.4 Using fluorescence, MolecuLight i:X quickly, safely, and easily visualises potentially harmful bacteria1,2,3 in wounds which may otherwise lack signs or symptoms of infection. It enhances a clinician’s ability to choose the right therapy, at the right time for their patient1,

Dr Amal Al Qubaisi Wins Parliamentarian Excellence Award as Best President of Arab Parliament11.12.2017 09:41Pressemelding

The Arab Inter-Parliamentary Union (AIPU) has honored Her Excellency Dr Amal Al Qubaisi, Speaker of the Federal National Council (FNC) – the United Arab Emirates parliament, with the Parliamentarian Excellence Award in the Presidents of Arab Parliaments category. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171211005411/en/ Her Excellency Dr Amal Al Qubaisi, Speaker of the Federal National Council (FNC) – the UAE parliament (Photo: AETOSWire) The award honors Al Qubaisi as ‘first female leader of a parliament in the Arab world’, celebrating her achievements on a national, regional and global scale, as well as the accomplishments made by FNC under her leadership. It also acknowledges the pioneering parliamentarian initiatives, projects and programs she has spearheaded and her significant contr

Financial Market Regulator Grants EU Payment License to DIMOCO Payment Services11.12.2017 08:00Pressemelding

The Austrian Financial Market Authority (FMA) granted a license under the Payment Service Act to DIMOCO Payment Services . The awarded license allows DIMOCO Payment Services to contribute to the payment value chain, offering merchants a single technical interface and a unified clearing & settlement process for many payment methods, including credit cards, online bank transfers, SEPA and direct debit cards. “We differ from most PSPs in the global payments ecosystem with our personal touch,” said Boris Kersten, Managing Director of DIMOCO Payment Services. “We proactively and personally monitor the overall payment process. In addition to monitoring individual transactions, we make recommendations and take actions to decrease chargebacks and fraudulent transactions. This process is not simply left to algorithms, the human element is added to the mix resulting in the protec

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom